Compare Eni SpA (E) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eni SpA vs DENTSPLY SIRONA Inc — how do they compare? Eni SpA trades at $48.17 (market cap $70.34B), while DENTSPLY SIRONA Inc trades at $13.93 (market cap $2.68B). The key difference: Eni SpA is far larger — about 26.2× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals.
| E | XRAY | |
|---|---|---|
Market Cap | $70.34B | $2.68B |
Sector | Energy | Health |
52-Week High | $57.61 | $16.85 |
52-Week Low | $32.93 | $9.64 |
Enterprise Value | $89.25B | $4.83B |
Dividend Yield | 4.99% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eni (E) trades at $48.11, down 2.91% over 24 hours, with a bullish technical signal supported by moving averages but mixed oscillators. The company shows stable cash flow generation with $238 million net cash flow in 2025, though revenue has declined from $132.5B in 2022 to $82.2B in 2025. Recent strategic moves include expanding into lithium, battery storage, and fusion energy partnerships, signaling diversification beyond traditional oil and gas.
The outlook balances diversification efforts against revenue pressures; the stock's low P/S of 0.79 and EV/EBITDA of 3.83 suggest undervaluation, but investors face risks from oil price volatility and execution challenges in new ventures. Analyst consensus is cautious with 61.53% hold ratings, reflecting uncertainty amid transition initiatives.
XRAY trades at $13.76, up 8.35% in 24 hours, with technical indicators showing a bullish trend. The stock has missed earnings estimates for three consecutive quarters, with Q2 2026 EPS expected at $0.36. Revenue declined to $3.68 billion in 2025, and the company reported a net loss of $598 million. Recent news highlights include distribution expansions and new AI-enabled product launches, while analyst sentiment remains mixed with a consensus price target of $13.33.
The outlook for XRAY is cautious due to persistent earnings misses and negative profitability, though technical momentum and strategic initiatives offer some upside potential. Key risks include margin pressure, high debt levels, and soft European demand. Investors should weigh the bullish technical signals against fundamental weaknesses before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
